PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Biophotonics. Author manuscript; available in PMC 2012 July 25.
Published in final edited form as:
PMCID: PMC3404621
NIHMSID: NIHMS390667

Bond-selective imaging of deep tissue through the optical window between 1600 and 1850 nm

Abstract

We report the employment of an optical window between 1600 nm and 1850 nm for bond-selective deep tissue imaging through harmonic vibrational excitation and acoustic detection of resultant pressure waves. In this window where a local minimum of water absorption resides, we found a 5 times enhancement of photoacoustic signal by first overtone excitation of the methylene group CH2 at 1730 nm, compared to the second overtone excitation at 1210 nm. The enhancement allows 3D mapping of intramuscular fat with improved contrast and of lipid deposition inside an atherosclerotic artery wall in the presence of blood. Moreover, lipid and protein are differentiated based on the first overtone absorption profiles of CH2 and methyl group CH3 in this window.

An external file that holds a picture, illustration, etc.
Object name is nihms390667u1.jpg

VPA imaging of atherosclerotic plaque with the presence of blood.

Keywords: optical window, deep tissue imaging, photoacoustic imaging, atherosclerosis

1. Introduction

Optical imaging of deep tissue has been a formidable challenge due to tissue absorption and scattering of both incident photons and generated signals. Owing to reduced scattering and minimal tissue absorption, near infrared (NIR) excitation and emission represent an effective method to enhance the optical penetration depth. NIR contrast agents including the indocyanine green [1], fluorescent protein [2], quantum dots [3], and single-walled carbon nanotubes [4] were developed and applied to live animal imaging. NIR fluorescence using contrast agents has enabled in vivo and ex vivo imaging of atherosclerosis [57]. On the excitation side, non-linear optical microscopy increased the penetration depth by using near-infrared (NIR) excitation [812]. In particular, excitation between 1000 to 1300 nm has allowed multiphoton imaging of vasculature in mouse brain at a depth of 1.0 mm [13]. Furthermore, use of adaptive optics has allowed deep tissue imaging at enhanced spatial resolution and signal strength [14].

Beyond the transport mean free path of the NIR light, which is around 1.0 mm in a soft tissue, photon propagation changes from the ballistic regime to diffusive regime [15]. Photoacoustic imaging [16], which utilizes absorbed light to produce local heating and subsequent thermal expansion and detection of the transient pressure waves by an ultrasound transducer, has allowed visualization of vasculature at visible wavelengths [17, 18]. PA imaging at NIR wavelengths is demonstrated by using nanostructures as contrast agents [1922]. Moreover, PA imaging at NIR wavelength region has also been applied to artery imaging and even towards the endoscopy [2328]. Among those studies, 1200 nm excitation has been demonstrated to allow label-free detection of lipid inside an artery wall [23, 2628]. In vibrational photoacoustic (VPA) microscopy, the contrast arises from harmonic vibration [23]. Compared to NIR spectroscopy [29], photoacoustic detection avoids scattering and allows depth-resolved signal collection.

Until now, the consensus is that the gold optical window lies between 650 and 1300 nm (grey shadow region). It is commonly believed that the window stops at 1300 nm due to significant water absorption at longer wavelengths. Nevertheless, we have realized that the water absorption between 1.0 and 3.0 μm is modulated by the vibration transition of H2O, namely the fundamental symmetric vibration ν1 and asymmetric vibration ν3 at ~2900 nm, ν2 (bending) + ν3 at ~1938 nm, ν1 + ν3 at ~1453 nm, second combinational transition at ~1200 nm, and second overtone transition at ~979 nm [3032] (Figure 1A). We note that a valley exists between 1600 and 1850 nm, where the absorption coefficient of pure water is at the same level as that of heme proteins in whole blood around 800 nm. Considering the reduced scattering and diminished phototoxicity at longer wavelength excitation, the wavelength region from 1600 to 1850 nm is appealing as a new optical window for deep tissue imaging (light red shadow region). Importantly, the first overtone of CH vibration, which has higher transition strength by one order of magnitude compared to the second overtone, is located at the same window of 1600 to 1850 nm. Such spectral features make it promising to perform label-free imaging by first overtone excitation and acoustic detection. In this paper we show photoacoustic imaging of arterial plaques by excitation of the first overtone of CH bond at 1730 nm from the lumen through a layer of whole blood. Furthermore, we show selective imaging of lipids and proteins by excitation of CH2 and CH3 in the same optical window.

Figure 1
(online color at: www.biophotonics-journal.org) Spectroscopy and imaging in the new optical window. (A) Absorption spectra of whole blood and pure water adapted from Ref. [30, 43]. (B) PA spectra of polyethylene, trimethylpentane, water and deuterium ...

2. Experimental

2.1 Vibrational photoacoustic spectroscopy and imaging

A Nd: YAG pumped optical parametric oscillator (OPO, Panther Ex Plus, Continuum) was utilized as the excitation source (Figure S1). The excitation module provides 10 Hz, 5 ns pulses laser with the wavelength range from 400 nm up to 2500 nm. The near-infrared light, produced at the idler beam from the OPO, was directed to an inverted microscope (IX71, Olympus) for spectroscopy and imaging purposes. The laser irradiation was focused by an achromatic doublet lens (30 mm focal length, Thorlabs). A focused-type, 20 MHz ultrasound transducer with a 50% bandwidth (V317, Olympus NDT) was employed to detect the photoacoustic signal. A 30 dB low noise preamplifier (5682, Olympus NDT) and a receiver (5073PR-15-U, Olympus NDT) with adjustable gain were applied for receiving signal. The signal was then sent to a digitizer (USB-5133, National Instrument), recorded by PC via a LabVIEW (National Instrument) program. VPA spectra were taken by automatic laser wavelength scanning of the OPO system. For the 3 dimensional (3-D) VPA imaging, a 2 dimensional (2-D) scanning stage (ProScan H117, Prior) was employed for the raster scanning. All 2-D images were reconstructed using a MATLAB program, while 3-D images and movies were built via ImageJ and Voxx [33], respectively.

2.2 Intramuscular fat sample

The muscle samples were harvested from goat and then preserved in 10% neutered-buffered formalin. The muscle chunk was then cut into ~10 × 10 × 4 mm pieces. The small muscle piece which contains a considerable amount of intramuscular fat was then placed in a glass bottom dish and embedded in D2O-agarose gel for imaging purposes.

2.3 Phantom construction

To measure the effect of water absorption, a PDMS wedged well was created in a cover glass bottom dish. Water was added into the well and covered by a polyethylene film which generated the VPA signal. The polyethylene film was then covered with 2.5% agarose-water gel. VPA amplitude as function of water layer thickness can be obtained by scanning the sample along the wedged direction. To measure the effect of the present of blood, we replaced the water with blood.

For lipid–protein differentiation, phantom was constructed by solid butter fat and tendon which extracted from the tail of a Sprague Dawley rat. Butter fat and rat tail tendon were embedded in agarose-D2O gel, and then covered by D2O as acoustic coupling medium.

2.4 Monte Carlo simulation

For evaluation of the effect of blood scattering and absorption to the VPA signal, a Monte Carlo simulation according to photon propagation in multilayered tissue method [34] was performed to calculate the excitation light attenuation by whole blood.

2.5 Artery samples from Ossabaw miniature swine model

Swine were fed high-fat/cholesterol/fructose diet, which was composed of 2% cholesterol, 20% kcal from fructose, and 43% kcal from hydrogenated soybean oil coconut oil, and lard [35]. Iliac arteries, including the bifurcation of the internal and external iliac arteries, were harvested and then preserved in 10% phosphate-buffered formalin. Before imaging was performed, arteries were washed by PBS and incised longitudinally for luminal imaging.

Detailed information on the materials and methods is included in the Supporting Information.

3. Results and discussion

To identify the valid contrast in the new window, we recorded the VPA spectra of major functional groups (see schematics of VPA imaging and spectroscopy system in Figure S1). Figure 1B shows the VPA spectra of CH2-rich polyethylene, CH3-rich trimethylpetane, water, and deuterium oxide (D2O). The new window is indicated by light red shadow. The spectrum of polyethylene provides the absorption profile of the methylene group (CH2), for which the first overtone (2ν CH2) shows two primary peaks around 1730 nm (5800 cm−1) and 1760 nm (5680 cm−1). The stronger peak at 1730 nm is generally thought to be a combination band of asymmetric and symmetric stretching (νa + νs) [32, 36]. The 1760 nm peak is assigned to the first overtone of stretching [32]. The second combination band of CH2, located between 1350 and 1500 nm, is attributed to the combination of harmonic stretching and non-stretching, such as bending, twisting and rocking (2ν + δ) [32]. The second overtone of CH2 is peaked around 1210 nm. Noticeably, the VPA amplitude at 1730 nm is around 6.3 times of that at 1210 nm.

The spectrum of trimethylpentane is mainly contributed by the absorption profile of methyl group (CH3). The primary peak around 1700 nm (5880 cm−1) is assigned to the first overtone of CH3 stretching. It is a remarkable fact that the CH2 and CH3 groups have distinguishable profiles at the first overtone region. The second combination band of CH3 starts from 1350 to 1500 nm with the main peak around 1380 nm, which is generally thought to be 2ν + δ [32]. The second overtone of CH3 shows the primary peak around 1195 nm.

The H2O band around 1450 nm, generally referred to as the first overtone of OH stretching, is a combination band of OH asymmetric and symmetric stretching (ν1 + ν3) [32]. The peak around 1940 nm is assigned to combination of bending and asymmetric stretching (ν2 + ν3) [32]. Excitingly, no water absorption peak is found in between the two combination bands, where the strong first overtones of CH2 and CH3 are located. Therefore, a potential optical window for imaging CH bond in deep tissue can be created at the water absorption ‘valley’ between 1600 and 1850 nm. For D2O, no significant absorption peak is found below 1900 nm, which indicates that D2O can be an ideal VPA coupling medium between excitation light and samples for VPA imaging and spectral measurements.

We used intramuscular fat to compare the amplitudes of VPA signals produced by first and second CH2 overtone absorption (Figure 1C). With the same pulse energy (45 μJ) for the 1730 and 1210 nm beams, the level of signal by first overtone absorption is 5 times of that by second overtone absorption. As the signal-to-noise ratio (SNR) in our setup is current limited by the electronic noise, which is constant when changing the laser intensity and wavelengths, using 1730 nm excitation also increased the SNR 5 times compared to the 1210 nm excitation. To confirm that the contrast indeed arose from the CH2 vibration, a VPA spectrum was taken from a fat marked with a green cross in the top panel of Figure 1C. As seen in the bottom panel, two primary peaks around 1730 and 1760 nm were detected, consistent with the CH2 absorption profile of polyethylene. A 3-D map of lipid network formed by intramuscular fat is shown in Movie S1. It was found that 3.5 mm penetration into the muscle tissue could be reached.

Because water absorption at 1730 nm is about 5 times larger than that at 1210 nm, we studied the effect of water absorption on the first and second CH2 overtone excitation, using a phantom shown in Figure 2A. By moving the sample from right to left and scanning the excitation wavelengths, the VPA spectra of polyethylene at different water thickness were obtained (Figure 2B). By increasing the water layer thickness, a greater decrease of signal at 1730 nm was seen. Nevertheless, the VPA signal produced by the first overtone remained larger than that by the second overtone when a water layer of 2.9 mm was added to the beam path. To validate the data, we theoretically computed the local light flux using the Beer-Lambert law for water absorption and calculated the PA signal ratio between the first and second overtone excitation, as shown in Figure 2C (red solid line). The calculation agrees well with the data, showing that 1730 nm excitation is beneficial even through 3 mm water absorption. With average pulse energy of 50 μJ in the focal volume, the temperature increase due to water absorption at 1730 nm is calculated to be 1.0 Kelvin. Experimentally, no cell damage was found at the pulse energy as high as 150 μJ (Figure S2).

Figure 2
(online color at: www.biophotonics-journal.org) Phantom study to evaluate the effect of water and blood on VPA imaging. (A) Schematic of the constructed phantom. PE: polyethylene. (B) VPA spectra of PE at different water layer thickness. (C) PA amplitude ...

Next we examined the benefit of 1730 nm excitation when scattering is taken into account. This is especially the case for detection of arterial plaques through whole blood which has scattering coefficient (μs = 600 cm−1 at 1200 nm) much larger than absorption coefficient (μa = 1.2 cm−1 at 1200 nm). To estimate how blood absorption and scattering affect the VPA signal, we used the same phantom construction as shown in Figure 2A, except that water was changed to rat whole blood in the wedged well. The VPA signals from polyethylene by 1730 and 1210 nm excitation were measured as a function of blood layer thickness. The results are shown in Figure 2D. At 0.5 mm blood, the signal at 1210 nm is fairly weak, whereas the signal at 1730 nm is as large as the signal at 1210 nm generated with 0.1 mm blood in the beam path. To validate the data, we calculated the light delivery efficiency using Monte Carlo simulation (see methods). The calculated signal amplitude agrees well with the experimental data (Figure 2D). The VPA signal at 1730 nm is 3 times larger than that at 1210 nm in the entire range of blood layer thickness from 0 to 0.8 mm. Specifically, when 0.5 mm blood layer presents, 1730 nm excitation gains 5 to 6 times in signal level compared to 1210 nm excitation. Such enhancement is largely owing to larger absorption by first CH overtone excitation.

We then employed the optical window between 1600 to 1850 nm to VPA imaging of an atherosclerotic artery from the lumen through a 0.5 mm thick layer of whole blood (Figure 3). The atherosclerotic illac artery was extracted from an Ossabaw pig atherogenic diet for 6 months [35]. The artery sample was cut open longitudinally and placed in a sample container (Figure 3A). A 0.5 mm thick layer of whole blood extracted from rat was inserted in the space between the sample and the coverslip. A focused ultrasound transducer was placed across the sample for forward receiving. The 3-D image by 1730 nm excitation is shown in Figure 3B and Movie S2. Lipid depositions as deep as 3.0 mm underneath the blood layer were detected. The blood layer gave a strong contrast, possibly because of the VPA signal from the blood components such as the heme proteins and water. Importantly, the artery sample and the blood layer can be well differentiated owing to the depth resolvability of photo-acoustic imaging. The advantage of using 1730 nm over 1210 nm excitation was shown by b-scan VPA imaging (Figure 3C, D). A signal reduction of 6 times was found when switching the laser to 1210 nm, resulting in disappearance of contrast from the lipid depositions (Figure 3D). The VPA spectrum (Figure 3E) of the lipid deposition matches the profile of first overtone of CH2.

Figure 3
(online color at: www.biophotonics-journal.org) VPA imaging and spectroscopy of arterial plaque in the presence of blood. (A) Schematic for VPA imaging of an artery through whole blood. (B) 3-D imaging of arterial plaque by 1730 nm excitation. Lumen and ...

We further demonstrated bond-selective VPA imaging of lipid and protein by making use of the distinctive spectral feature of CH2 and CH3 groups in the first overtone region. Phantoms composed of butter fat containing CH2-rich lipid and rat tail tendon containing type I collagen were used to demonstrate this concept. Figure 4A shows the VPA spectra of butter fat and rat tail tendon. The fat shows two peaks at 1730 and 1760 nm, corresponding to the first overtone transitions of CH2. The type I collagen shows a shoulder that appears below 1700 nm, contributed by the CH3 groups. Note the much lower VPA signal from the tendon, which is more discernable in the spectrum because the display gain was 15-fold higher. VPA imaging of the phantom sample was performed (Figure 4B, C). The result shows that lipid and protein can be differentiated using 1730 and 1640 nm excitation. Such capability was applied to 3-D VPA imaging of the outer layer of an intact artery composed of perivascular fat and adventitia. The artery was placed in the glass bottom dish and stabilized by D2O agarose gel (Figure S3A). Figures 4D–F show images at selected x-z plane and Figures 4G–I show images at selected x-y plane through the adventitia. The 3-D image is shown in Figure S3B and Movie S3. The contrast at 1640 nm illustrates the location of proteins whereas the contrast at 1730 shows the distribution of vascular fat. VPA spectra taken at selected position (Figure S3C) confirmed that these contrasts were contributed by signals from CH3 and CH2, respectively. Moreover, bond-selective 3-D imaging of an atherosclerotic plaque by 1640 and 1730 nm excitation from the lumen side (Movie S4) showed different contrasts from protein content (cyan color) and lipid deposition (yellow color).

Figure 4
(online color at: www.biophotonics-journal.org) Bond-selective VPA imaging to differentiate lipid and protein. (A) VPA spectra of butter fat and rat tail tendon. (BC) B-scan VPA imaging of butter fat – tendon phantom using 1640 nm (B ...

4. Conclusion

A variety of advanced techniques have been developed to characterize the atherosclerotic plaque [37, 38], including multidetector spiral computed tomography [39], magnetic resonance imaging [37, 40], intravascular ultrasound [41], optical coherent tomography [42] and intravascular near infrared spectroscopy [29]. As shown here, label-free imaging atherosclerotic plaques can be performed through optical excitation of first overtones of CH bonds and acoustic detection of the generated ultrasound waves in a previously underappreciated optical window (1.6 to 1.85 μm). Furthermore, selective VPA imaging of collagen and lipids heralds the potential in diagnosis of vulnerable plaques through detection of the thickness of the collagen cap and the location of the lipid-laden plaque inside the arterial wall without molecular labeling that could alter tissue composition. Collectively the current work opens new opportunities for label-free imaging of lipid-laden plaques in atherosclerosis and other medical conditions.

Biographies

An external file that holds a picture, illustration, etc.
Object name is nihms390667b1.gif

Pu Wang received the B.S. degree in physics from Fudan University, Shanghai, China, in 2007, and M.S. degree in medical biophysics from Indiana University School of Medicine, Indianapolis, IN, in 2009.

He is currently working toward the Ph.D degree in biomedical engineering at Purdue University, West Lafayette, IN. His research interests include non-linear and linear optical imaging and microscopy, and photoacoustic imaging and spectroscopy.

An external file that holds a picture, illustration, etc.
Object name is nihms390667b2.gif

Han-Wei Wang received his Ph.D. degree at Purdue University under the supervision of Dr. Ji-Xin Cheng. He is currently working at Weldon School of Biomedical Engineering at Purdue University as a postdoctoral research associate. His research specialties are developments and applications of novel biomedical imaging techniques including molecular photoacoustic imaging, nonlinear optical microscopy, fiber-optics detection, and imaging and bioanalytical instrumentation.

An external file that holds a picture, illustration, etc.
Object name is nihms390667b3.gif

Michael Sturek received his B.A. from Augustana College in 1979, M.S. from Purdue University in 1980, and Ph.D. from the University of Iowa in 1985. Sturek is currently Professor and Chair of Cellular & Integrative Physiology at Indiana University School of Medicine and Professor of Biomedical Engineering at Purdue University. Major efforts are in chronic effects of diabetes and atherosclerosis and translation of novel methods to label-free imaging of arterial plaque composition, including development of intravascular imaging catheter methods using novel swine models of cardiovascular disease.

An external file that holds a picture, illustration, etc.
Object name is nihms390667b4.gif

Ji-Xin Cheng received B.S degree and Ph.D degree in Department of Chemical Physics from University of Science and Technology of China, Hefei, China, in 1994 and 1998, respectively. He is currently an Associate Professor at Weldon School of Biomedical Engineering at Purdue University, West Lafayette, IN. His research lab develops label-free optical imaging tools and nano-technologies for challenging applications in biomedicine such as early detection of tumor spread and early nerve repair after traumatic spinal cord injury.

Footnotes

Supporting information for this article is available free of charge under http://dx.doi.org/10.1002/jbio.201100102

References

1. Escobedo JO, Rusin O, Lim S, Strongin RM. Curr Opin Chem Biol. 2010;14(1):64–70. [PMC free article] [PubMed]
2. Filonov GS, Piatkevich KD, Ting L-M, Zhang J, Kim K, Verkhusha VV. Nat Biotech. 2011;29(8):757–761. [PMC free article] [PubMed]
3. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Science. 2005;307(5709):538–544. [PMC free article] [PubMed]
4. Welsher K, Sherlock SP, Dai H. Proceedings of the National Academy of Sciences. 2011;108(22):8943–8948. [PubMed]
5. Wentzel JJ, van der Giessen AG, Garg S, Schultz C, Mastik F, Gijsen FJH, Serruys PW, van der Steen AFW, Regar E. Circulation: Cardiovascular Imaging. 2010;3(6):e6–e7. [PubMed]
6. Jaffer FA, Calfon MA, Rosenthal A, Mallas G, Razansky RN, Mauskapf A, Weissleder R, Libby P, Ntziachristos V. J Am Coll Cardiol. 2011;57(25):2516–2526. [PMC free article] [PubMed]
7. Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, Ntziachristos V, Weissleder R, Libby P, Jaffer FA. Science Translational Medicine. 2011;3(84):84ra45. [PMC free article] [PubMed]
8. Denk W, Strickler J, Webb W. Science. 1990;248(4951):73–76. [PubMed]
9. Helmchen F, Denk W. Nat Meth. 2005;2(12):932–940. [PubMed]
10. Andresen V, Alexander S, Heupel W-M, Hirschberg M, Hoffman RM, Friedl P. Curr Opin Biotech. 2009;20(1):54–62. [PubMed]
11. Yue S, Slipchenko MN, Cheng JX. Laser & Photonics Reviews. 2011;5(4):496–512.
12. Min W, Freudiger CW, Lu S, Xie XS. Annu Rev Phys Chem. 2011;62(1):507–530. [PMC free article] [PubMed]
13. Kobat D, Durst ME, Nishimura N, Wong AW, Schaffer CB, Xu C. Opt Express. 2009;17(16):13354–13364. [PubMed]
14. Ji N, Milkie DE, Betzig E. Nat Meth. 2010;7(2):141–147. [PubMed]
15. Wang LV, Wu H-i. Biomedical Optics: Principles and Imaging. Wiley; 2007.
16. Wang LV. Photoacoustic imaging and spectroscopy. CRC Press; 2009.
17. Zhang HF, Maslov K, Stoica G, Wang LV. Nat Biotech. 2006;24(7):848–851. [PubMed]
18. Wang X, Pang Y, Ku G, Xie X, Stoica G, Wang LV. Nat Biotech. 2003;21(7):803–806. [PubMed]
19. Kim C, Song H-M, Cai X, Yao J, Wei A, Wang LV. J Mater Chem. 2011;21(9):2841–2844. [PMC free article] [PubMed]
20. Akers WJ, Kim C, Berezin M, Guo K, Fuhrhop R, Lanza GM, Fischer GM, Daltrozzo E, Zumbusch A, Cai X, Wang LV, Achilefu S. ACS Nano. 2010;5(1):173–182. [PMC free article] [PubMed]
21. Kim J-W, Galanzha EI, Shashkov EV, Moon H-M, Zharov VP. Nat Nano. 2009;4(10):688–694. [PMC free article] [PubMed]
22. De La Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma T-J, Oralkan O, Cheng Z, Chen X, Dai H, Khuri-Yakub BT, Gambhir SS. Nat Nano. 2008;3(9):557–562. [PMC free article] [PubMed]
23. Wang H-W, Chai N, Wang P, Hu S, Dou W, Umulis D, Wang LV, Sturek M, Lucht R, Cheng J-X. Phys Rev Lett. 2011;106(23):238106. [PMC free article] [PubMed]
24. Razansky D, Harlaar N, Hillebrands J, Taruttis A, Herzog E, Zeebregts C, van Dam G, Ntziachristos V. Molecular Imaging and Biology. 2011 Jul; [Epub ahead of print]
25. Bo W, Su JL, Karpiouk AB, Sokolov KV, Smalling RW, Emelianov SY. IEEE J Selected Topics in Quantum Electronics. 2010;16(3):588–599. [PMC free article] [PubMed]
26. Jansen K, van der Steen AFW, van Beusekom HMM, Oosterhuis JW, van Soest G. Optics Letter. 2011;36(5):597–599. [PubMed]
27. Wang B, Su JL, Amirian J, Litovsky SH, Smalling R, Emelianov S. Opt Express. 2010;18(5):4889–4897. [PMC free article] [PubMed]
28. Allen T, Hall A, Dhillon A, Owen J, Beard P. Proc SPIE. 2010;7564(1):75640C.
29. Caplan JD, Waxman S, Nesto RW, Muller JE. J Am Coll Cardiol. 2006;47(8 Supplement 1):C92–C96. [PubMed]
30. Hale GM, Querry MR. Appl Optics. 1973;12(3):555–563. [PubMed]
31. Kou L, Labrie D, Chylek P. Appl Optics. 1993;32 (19):3531–3540. [PubMed]
32. Jerry Workman LW. Practical guide to interpretive near-infrared spectroscopy. CRC Press; 2007.
33. Clendenon JL, Phillips CL, Sandoval RM, Fang S, Dunn KW. Am J Physiol – Cell Physiology. 2002;282(1):C213–C218. [PubMed]
34. Wang LV, Jacques SL, Zheng L. Comput Meth Prog Bio. 1995;47(2):131–146. [PubMed]
35. Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, Sturek M, Chalasani N. Hepatology. 2009;50(1):56–67. [PMC free article] [PubMed]
36. Ricard-Lespade L, Longhi G, Abbate S. Chem Phys. 1990;142(2):245–259.
37. Sanz J, Fayad ZA. Nature. 2008;451(7181):953–957. [PubMed]
38. Fayad ZA, Fuster V. Circ Res. 2001;89(4):305–316. [PubMed]
39. Achenbach S, Moselewski F, Ropers D, Ferencik M, Hoffmann U, MacNeill B, Pohle K, Baum U, Anders K, Jang I-K, Daniel WG, Brady TJ. Circulation. 2004;109(1):14–17. [PubMed]
40. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JGS, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Proceedings of the National Academy of Sciences. 2007;104(3):961–966. [PubMed]
41. Nissen SE, Yock P. Circulation. 2001;103(4):604–616. [PubMed]
42. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang I-K, Schlendorf KH, Kauffman CR, Shishkov M, Kang D-H, Halpern EF, Tearney GJ. Circulation. 2002;106(13):1640–1645. [PubMed]
43. Takatani S, Graham MD. Biomedical Engineering, IEEE Transactions on BME. 1979;26(12):656–664. [PubMed]